|
⚲
|
| Keyboard |
| Inscobee Inc
✚
|
|
|---|---|
| CIK # | 0002057997 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002057997] | |
| 4 | [0002057997] | |
| SC 13D | [0002057997] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Inscobee Inc | Apimeds Pharmaceuticals US Inc | [2025-05-19] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Apimeds Pharmaceuticals US Inc | |
| Inscobee Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Apimeds Pharmaceuticals US Inc APUS
Common Stock, par value $0.01 per share
|
2025-05-12 | Conversion | 44,041 | $2.60 | 114,507 |
|
Apimeds Pharmaceuticals US Inc APUS
Common Stock, par value $0.01 per share
|
2025-05-12 | Conversion | 71,090 | $2.60 | 184,834 |
|
Apimeds Pharmaceuticals US Inc APUS
Common Stock, par value $0.01 per share
|
2025-05-12 | Conversion | 182,002 | $2.60 | 473,205 |
|
Apimeds Pharmaceuticals US Inc APUS
Common Stock, par value $0.01 per share
|
2025-05-12 | Buy | 500,000 | $4.00 | 2,000,000 |
|
Apimeds Pharmaceuticals US Inc APUS
Convertible Promissory Note · derivative
|
2025-05-12 | Conversion | $0.00 | ||
|
Apimeds Pharmaceuticals US Inc APUS
Convertible Promissory Note · derivative
|
2025-05-12 | Conversion | $0.00 | ||
|
Apimeds Pharmaceuticals US Inc APUS
Convertible Promissory Note · derivative
|
2025-05-12 | Conversion | $0.00 |